MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/gs-2026-0244

Медицинская библиотека · Gland surgery · 2026

Factors influencing postoperative thyroid-stimulating hormone suppression therapy in low-risk papillary thyroid cancer after lobectomy.

Dong Bingbin, Xiao Shuguang, Wang Zheng, Wang Yabing

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Thyroid-stimulating hormone (TSH) suppression therapy remains an important treatment option for patients with low-risk differentiated thyroid cancer (DTC). This study aimed to analyze the potential influencing factors affecting TSH suppression outcomes in patients with postoperative low-risk papillary thyroid cancer (PTC).

METHODS

A total of 223 low-risk PTC patients were enrolled in this single-center cross-sectional study between September 2024 and February 2025. Based on the TSH level measured at 4-6 months post-lobectomy, the patients were divided into three groups: an excessive TSH suppression group (TSH <0.5 mU/L), optimal TSH suppression group (TSH 0.5-2.0 mU/L), and insufficient TSH suppression group (TSH >2.0 mU/L). The clinicopathological data of the patients, including demographic, clinical laboratory, pathological, and lifestyle characteristics, were analyzed to investigate the factors influencing TSH suppression therapy.

RESULTS

There were no statistically significant differences in age, marital status, preoperative free triiodothyronine (FT3), free thyroxine (FT4), thyroglobulin antibody (TG-Ab), thyroid peroxidase antibody (TPO-Ab), thyroglobulin (Tg) level, longest tumor diameter, lesion site, central lymph node metastasis, Hashimoto's thyroiditis, BRAF V600E mutation, levothyroxine intake habits, dietary habits, or sleep habits among the three groups (all P>0.05). The distributions of sex, body mass index (BMI), comorbidities, preoperative TSH levels, multifocal lesions, levothyroxine dose, physical activity, and sedentary time differed significantly among the three groups (all P<0.05). Multivariate logistic regression analyses demonstrated that excessive TSH suppression was significantly associated with female sex, a higher levothyroxine dose (≥1.6 µg/kg/day), lower preoperative TSH levels, lower physical activity, and higher sedentary time. Conversely, insufficient TSH suppression was independently associated with higher BMI and lower levothyroxine dose (<1.6 µg/kg/day).

CONCLUSIONS

A complex interplay exists among demographic, clinical, and lifestyle factors in postoperative TSH management. Prospective studies with objective lifestyle measurements are needed to confirm these associations before clinical implementation.

Для цитирования: Dong Bingbin, Xiao Shuguang, Wang Zheng, Wang Yabing. Factors influencing postoperative thyroid-stimulating hormone suppression therapy in low-risk papillary thyroid cancer after lobectomy.. Gland surgery. 2026. DOI: 10.21037/gs-2026-0244.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.